QV Bioelectronics is delighted to announce that Dr Paul Brennan will be joining our clinical advisory board & our design input group!
Paul is Reader and Honorary Consultant Neurosurgeon at the University of Edinburgh and NHS Lothian. He combines his operative expertise with laboratory and clinical research into brain tumours. He has expertise in MedTech innovation, and led the clinical translation of an innovative brain tumour blood test from the lab to the clinic, supporting successful significant external investment.
Complementing his clinical work, Paul founded eoSurgical Ltd in 2012 along with co-founders Roland Partridge and Mark Hughes. This University of Edinburgh spin-out now provides surgical simulation training in 85 countries. In 2014 Paul helped in the foundation of the Compassion Initiative at the University of Edinburgh.
His research and clinical expertise is well placed to positively impact our project and team. As an advisor, Paul brings with him a wealth of experience and expertise as we continue to pioneer life-extending treatment options for terminal cancer patients.